Total Payments
$9,103
2021 Payments
$31.22
Companies
39
Transactions
221
Medicare Patients
931
Medicare Billing
$140,567
Payment Breakdown by Category
Consulting$5,350 (58.8%)
Food & Beverage$3,546 (39.0%)
Travel$170.00 (1.9%)
Education$36.92 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,350 | 2 | 58.8% |
| Food and Beverage | $3,546 | 214 | 39.0% |
| Travel and Lodging | $170.00 | 2 | 1.9% |
| Education | $36.92 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $3,310 | 8 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $2,998 | 26 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $555.52 | 42 | $0 (2018) |
| PFIZER INC. | $335.56 | 31 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $250.30 | 15 | $0 (2018) |
| Genentech USA, Inc. | $236.07 | 18 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $210.34 | 13 | $0 (2018) |
| Spectrum Pharmaceuticals Inc. | $126.08 | 7 | $0 (2018) |
| TESARO, Inc. | $78.23 | 4 | $0 (2017) |
| EMD Serono, Inc. | $75.14 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $31.22 | 2 | Janssen Biotech, Inc. ($19.30) |
| 2019 | $21.89 | 1 | EMD Serono, Inc. ($21.89) |
| 2018 | $1,019 | 66 | AstraZeneca Pharmaceuticals LP ($176.74) |
| 2017 | $8,031 | 152 | Gilead Sciences Inc ($3,298) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 01/08/2021 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Oncology | ||||||
| 02/07/2019 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Oncology | ||||||
| 10/24/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2018 | PFIZER INC. | XALKORI (Drug), IBRANCE | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Anemia | ||||||
| 08/15/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2018 | MEDIVATION FIELD SOLUTIONS LLC | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2018 | Novartis Pharmaceuticals Corporation | JADENU (Drug), PROMACTA | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: HEMATOLOGY | ||||||
| 08/07/2018 | Kyowa Kirin, Inc. | FARESTON (Drug), SANCUSO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: SERM | ||||||
| 08/02/2018 | Spectrum Pharmaceuticals Inc. | Zevalin (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Oncology | ||||||
| 07/30/2018 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: BioOncology | ||||||
| 07/24/2018 | MEDIVATION FIELD SOLUTIONS LLC | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2018 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR, VOTRIENT | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ONCOLOGY | ||||||
| 07/10/2018 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Oncology | ||||||
| 07/09/2018 | Novartis Pharmaceuticals Corporation | JADENU (Drug), PROMACTA | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: HEMATOLOGY | ||||||
| 07/02/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Anemia | ||||||
| 06/26/2018 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Oncology | ||||||
| 06/25/2018 | PFIZER INC. | BOSULIF (Drug), XTANDI | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 06/19/2018 | PFIZER INC. | XALKORI (Drug), IBRANCE | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2018 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Virology | ||||||
| 06/12/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.57 | General |
| Category: Oncology | ||||||
| 06/04/2018 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Prostate Cancer | ||||||
| 05/30/2018 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 240 | 376 | $99,391 | $39,960 |
| 2022 | 4 | 257 | 387 | $93,077 | $36,138 |
| 2021 | 3 | 245 | 369 | $94,660 | $36,902 |
| 2020 | 3 | 189 | 257 | $68,362 | $27,567 |
Total Patients
931
Total Services
1,389
Medicare Billing
$140,567
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 140 | 269 | $66,252 | $26,625 | 40.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 78 | 83 | $29,857 | $12,010 | 40.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 13 | $2,131 | $860.86 | 40.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 11 | $1,151 | $463.54 | 40.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 157 | 283 | $60,382 | $23,771 | 39.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 67 | 68 | $28,149 | $10,571 | 37.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 24 | $3,565 | $1,434 | 40.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 12 | $980.40 | $362.34 | 37.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 138 | 255 | $54,830 | $21,668 | 39.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 84 | 85 | $35,486 | $13,557 | 38.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 29 | $4,344 | $1,678 | 38.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 105 | 169 | $37,217 | $14,979 | 40.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 61 | 64 | $27,478 | $11,101 | 40.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 24 | $3,668 | $1,487 | 40.5% |
About Dr. Paul Hyman, MD
Dr. Paul Hyman, MD is a Hematology & Oncology healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659354280.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Hyman, MD has received a total of $9,103 in payments from pharmaceutical and medical device companies, with $31.22 received in 2021. These payments were reported across 221 transactions from 39 companies. The most common payment nature is "Consulting Fee" ($5,350).
As a Medicare-enrolled provider, Hyman has provided services to 931 Medicare beneficiaries, totaling 1,389 services with total Medicare billing of $140,567. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Boca Raton, FL
- Active Since 11/29/2005
- Last Updated 02/15/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1659354280
Products in Payments
- Zydelig (Drug) $3,282
- KEYTRUDA (Biological) $208.52
- IMFINZI (Drug) $155.70
- TAGRISSO (Drug) $148.46
- TASIGNA (Drug) $122.58
- OPDIVO (Biological) $118.82
- IBRANCE (Drug) $114.84
- JADENU (Drug) $97.26
- KISQALI (Drug) $95.21
- EMPLICITI (Biological) $91.52
- SUTENT (Drug) $85.87
- Zevalin (Drug) $77.96
- Bavencio (Biological) $75.14
- AFINITOR (Drug) $66.21
- Avastin (Biological) $63.96
- MEKINIST (Drug) $62.47
- FASLODEX (Drug) $61.69
- INJECTAFER (Drug) $57.61
- BOSULIF (Drug) $57.28
- XTANDI (Drug) $56.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Boca Raton
Mohammad Jahanzeb, Md, MD
Hematology & Oncology — Payments: $1.3M
Hematology & Oncology $1.3M
Dr. Fernando Recio, Md, MD
Hematology & Oncology — Payments: $26,134
Hematology & Oncology $26,134
Dr. Liat Dagan, Md, MD
Hematology & Oncology — Payments: $9,194
Hematology & Oncology $9,194
Dr. Bachir Berbari, Md, MD
Hematology & Oncology — Payments: $6,995
Hematology & Oncology $6,995
Dr. Steven Morris, M.d, M.D
Hematology & Oncology — Payments: $6,937
Hematology & Oncology $6,937
Dr. Aurea Tomeski, M.d, M.D
Hematology & Oncology — Payments: $22.15
Hematology & Oncology $22.15